================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) MARCH 7, 2005
PSYCHEMEDICS CORPORATION
(Exact Name of Registrant As Specified In Its Charter)
DELAWARE
(State if Other Jurisdiction of Incorporation)
1-13738 58-1701987
(Commission File Number) (I.R.S. Employer Identification No.)
125 NAGOG PARK, ACTON, MASSACHUSETTS 01720
(Address of Principal Executive Offices) (Zip Code)
(978) 206-8220
(Registrant's Telephone Number, Including Area Code)
1280 MASSACHUSETTS AVE., SUITE 200, CAMBRIDGE, MA 02138
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instructions A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On March 7, 2005, Psychemedics Corporation issued a press release
announcing preliminary results for the fourth quarter and year ended December
31, 2004. A copy of the press release is attached hereto as Exhibit 99.1 and
incorporated by reference herein.
LIMITATION ON INCORPORATION BY REFERENCE. The information in this Form
8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 or the
Exchange Act, regardless of any general incorporation language in such filing.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS. Except for
historical information contained in the press release attached as an exhibit
hereto, the press release contains forward-looking statements which involve
certain risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by these statements. Please refer to
the cautionary note in the press release regarding these forward-looking
statements.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
The following exhibits are filed herewith:
99.1 Press Release dated March 7, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
PSYCHEMEDICS CORPORATION
Dated: March 9, 2005
By: /s/ Peter C. Monson
--------------------------------------
Peter C. Monson, Vice President and
Chief Financial Officer
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
99.1 Press release dated March 7, 2005 of Psychemedics Corporation
announcing its financial results for the fourth quarter and year
ended December 31, 2004.